undefined undefined
NaN.000
NaN.00%
Sanofi SA (SNY) has released an update. Sanofi’s new treatment for relapsing mu...
05-03 04:59
Regeneron Pharmaceuticals Q1 2024 earnings: EPS down 5%, sales miss; Eylea US sales drop 16%, Dupixent offsets. Oncology treatment Libtayo sales surge 49%.
05-03 03:49
In the ever-evolving and intensely competitive business landscape, conducting a...
05-02 23:00
Regeneron Pharmaceuticals (NASDAQ:REGN) traded lower in the premarket Thursday despite a newly announced $3B worth of share buybacks as the Eylea maker fell short of Street forecasts with its Q1 2024 ...
05-02 19:55
Benzinga's options scanner has just identified more than 16 option transactions...
04-30 22:31
Bristol Myers Squibb (NYSE:BMY) and Repertoire Immune Medicines have entered a multi-year strategic collaboration to develop tolerizing vaccines for up to three autoimmune diseases. Pursuant to the de...
04-29 18:56
来源:华兴资本 “华兴资本医疗与生命科技行业周报”定期发布,专注从资本角度解读一周数据,并提供最新行业观察。 医疗与生命科技是华兴资本多年来关注并深耕的领域,目...
04-29 10:36
Orphan drugs -- medicines to treat rare diseases -- from Johnson & Johnson (NYSE:JNJ), Roche (OTCQX:RHHBY), and AstraZeneca (NASDAQ:AZN) will allow these companies to reign as the top 3 orphan drugmak...
04-29 01:00
Kepler Capital analyst Christopher Richardson, CFA maintained a Hold rating on ...
04-27 09:45
The European Medicines Agency's Committee for Medicinal Products for Human Use has issued positive opinions for treatments from Bristol-Myers Squibb (NYSE:BMY), Sanofi (NASDAQ:SNY), and Takeda Pharmac...
04-27 02:32